comprehensive
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: After Optum profits sink, UnitedHealth makes changes
Next article: After Optum profits sink, UnitedHealth makes changes
knowledge
hotspot
-
Pfizer plans to depart BIO
2025-10-06 19:50 -
Indictment alleges Trump's ex
2025-10-06 18:45 -
Why sickle cell disease is getting the first CRISPR treatment
2025-10-06 18:20 -
BMS, looking to build heart drug business, turns to AI for diagnosis
2025-10-06 18:04 -
FDA needs staff influx to meet gene therapy needs, Marks says
2025-10-06 17:50 -
SCOTUS to consider access to abortion pill mifepristone
2025-10-06 17:41